Daily Derm Times: March 25, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 3

In part 3 of this Frontline Forum supplement, experts discuss surgical innovations in HS, setting treatment expectations, and more.

New Study Compares Topical Serum and Pulse Light Therapy for Rosacea

Each treatment had benefits and disadvantages for patients who struggle with rosacea-associated erythema.

Nanoneedles Enhance CRISPR Base Editing for RDEB Treatment, Achieving 96.5% Correction Efficiency

Nanoneedles boosted CRISPR base editing efficiency in RDEB fibroblasts, enabling precise COL7A1 correction and improved cell function.

Understanding Neomycin-Induced Contact Allergy

Research suggests that neomycin allergy may be underdiagnosed despite its common use in medical and cosmetic formulations.

Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease

A study reveals that biologics targeting IL-12, IL-23, and IL-17 lower the risk of serious infections in older adults with psoriatic disease.

Quoin Files US Patent Applications for Rare Disease Treatment

The novel treatments will be for patients with orphan conditions like Netherton Syndrome, Peeling Skin Syndrome, SAM Syndrome, and palmoplantar keratoderma.

Expert Recommendations for Personalized AD Treatment

An expert panel of clinicians provided insights on first-line treatments, maintenance strategies, and flare management for AD.